C-GLUCURONIDES, A NOVEL TYPE OF DRUG METABOLITESRICHTER WJ; ALT KO; DIETERLE W et al.1975; HELV. CHIM. ACTA; SUISSE; DA. 1975; VOL. 58; NO 8; PP. 2512-2517; BIBL. 8 REF.Article

Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cdna-expressed cytochrome P450sMINXIA HE; RETTIE, Allan E; NEAL, John et al.Drug metabolism and disposition. 2001, Vol 29, Num 5, pp 701-711, issn 0090-9556Article

Pharmacologie des médicaments antiagrégants = Pharmacology of antiplatelet drugsDE GAETANO, G; CERLETTI, C.Entretiens du Carla (Les). 1985, Vol 4, pp 45-55Article

Drug-related changes in platelet shape in whole bloodROSENSTEIN, R.Thrombosis research. 1985, Vol 39, Num 5, pp 613-618, issn 0049-3848Article

ON THE INHIBITING EFFECT OF SULFINPYRAZONE ON PLATELETSCORTELLARO M; POLLI EE.1979; THROMBOSIS RES.; GBR; DA. 1979; VOL. 15; NO 5-6; PP. 895-896; BIBL. 5 REF.Article

PROLONGED INHIBITION OF EX VIVO SODIUM ARACHIDONATE-INDUCED PLATELET AGGREGATION AND MALONDIALDEHYDE (MDA) PRODUCTION BY SULPHINPYRAZONE (ANTURAN) IN MANMAGUIRE ED; PAY GF; WALLIS RB et al.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 21; NO 3; PP. 321-327; BIBL. 14 REF.Article

DRUG SPOTLIGHT PROGRAM: MANAGEMENT OF GOUTSIMKIN PA.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 5; PP. 812-816; BIBL. 23 REF.Article

ACCION DE SULFINPIRAZONA SOBRE LOS LIPIDOS SANGUINEOS. = ACTION DE LA SULFINPYRAZONE SUR LES LIPIDES SANGUINSJIMENEZ LOPEZ A; SANCHEZ MARTIN S.1977; REV. CLIN. ESP.; ESP.; DA. 1977; VOL. 146; NO 1-2; PP. 65-67; ABS. ANGL. ALLEM. FR.; BIBL. 19 REF.Article

Antiplatelet therapy in thrombotic thrombocytopenic purpuraDEL ZOPPO, G. J.Seminars in hematology. 1987, Vol 24, Num 2, pp 130-139, issn 0037-1963Article

Three simple spectrophotometric methods for the determination of sulphinpyrazoneSASTRY, C. S. P; SAILAJA, A; THIRUPATHI RAO, T et al.Talanta (Oxford). 1992, Vol 39, Num 6, pp 709-713, issn 0039-9140Article

THE EFFECT OF SULFINPYRAZONE ON THE RESPONSE TO SYMPATHETIC NERVOUS SYSTEM STIMULATIONKELLIHER GJ; FASOLAK W; JURKIEVICZ N et al.1982; PROSTAGLANDINS LEUKOTRIENES MED.; GBR; DA. 1982; VOL. 8; NO 1; PP. 63-71; BIBL. 21 REF.Article

INHIBITION OF SPONTANEOUS PLATELET AGGREGATION BY SULFINPYRAZONENENCI GG; AGNELLI G; BERRETTINI M et al.1979; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1979; VOL. 42; NO 2; PP. 621-625; ABS. FRE/GER; BIBL. 20 REF.Article

SULFINPYRAZONE AFTER MYOCARDIAL INFARCTIONWESTON MJ.1979; AMER. HEART J.; USA; DA. 1979; VOL. 98; NO 4; PP. 537-538; BIBL. 13 REF.Article

L'AGREGATION PLAQUETTAIRE ET SON APPROCHE THERAPEUTIQUECASTAIGNE A; BENGOZI R.1979; CONCOURS MED.; FRA; DA. 1979; VOL. 101; NO 19; PP. 3141-3155; (9 P.); BIBL. 17 REF.Article

DRUG CONTROL OF GOUT AND HYPERURICAEMIA.EMMERSON BT.1978; DRUGS; CHE; DA. 1978; VOL. 16; NO 2; PP. 158-166; BIBL. 2 REF.Article

INFLUENCE OF SULPHINPYRAZONE (ANTURAN) ON THROMBOELASTOGRAPHY.LEUTENEGGER F; MICHOT F.1978; J. INTERNATION. MED. RES.; G.B.; DA. 1978; VOL. 6; NO 2; PP. 133-135; BIBL. 9 REF.Article

PLATELET-SUPPRESSANT THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASESTEELE P; RAINWATER J; VOGEL R et al.1978; J.A.M.A.; USA; DA. 1978; VOL. 240; NO 3; PP. 228-231; BIBL. 30 REF.Article

QUANTITATIVE ASSAY OF SULPHINPYRAZONE IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.LECAILLON JB; SOUPPART C.1976; J. CHROMATOGR.; NETHERL.; DA. 1976; VOL. 121; NO 2; PP. 227-234; BIBL. 4 REF.Article

THE ROLE OF SULFINPYRAZONE IN THE PREVENTION OF ARTERIO-VENOUS SHUNT TROMBOSIS. = ROLE DE LA SULFINPYRAZONE DANS LA PREVENTION DE LA THROMBOSE DES COURT-CIRCUITS ARTERIO-VEINEUXKAEGI A; PINEO GF; SHIMIZU A et al.1975; CIRCULATION; U.S.A.; DA. 1975; VOL. 52; NO 3; PP. 497-499; BIBL. 5 REF.Article

BIOTRANSFORMATION AND PHARMACOKINETICS OF SULFINPYRAZONE (ANTURAN) IN MAN.DIETERLE W; FAIGLE JW; MORY H et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 9; NO 2-3; PP. 135-145; BIBL. 16 REF.Article

TRANSFORMATION AND EXCRETION OF DRUGS IN BIOLOGICAL SYSTEMS. IX. INTERACTIONS BETWEEN SULFINPYRAZONE AND SULFONAMIDES, AND BETWEEN OXYPHENBUTAZONE AND SULFONAMIDES IN DOGSTAKADA M; MISAWA A; FUJIMOTO K et al.1974; CHEM. PHARM. BULL.; JAP.; DA. 1974; VOL. 22; NO 3; PP. 551-559; BIBL. 27REF.Article

Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9KERDPIN, Oranun; ELLIOT, David J; MACKENZIE, Peter I et al.Drug metabolism and disposition. 2006, Vol 34, Num 12, pp 1950-1953, issn 0090-9556, 4 p.Article

Sulfinpyrazone reduces cyclosporine levels : A new drug interaction in heart transplant recipientsCAFORIO, A. L. P; GAMBINO, A; TONA, F et al.The Journal of heart and lung transplantation. 2000, Vol 19, Num 12, pp 1205-1208, issn 1053-2498Article

Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessmentBERTOLI, L; BUSNARDO, I; BORGHI, C et al.Pharmacological research communications. 1985, Vol 17, Num 3, pp 299-306, issn 0031-6989Article

Warfarin―sulfinpyrazone interaction on binding to human serum albuminLARSEN, F. G; LARSEN, C. G; BRODERSEN, R et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 10, pp 689-690, issn 0022-3573Article